Switch to: References

Add citations

You must login to add citations.
  1. Stakeholder views of ethical guidance regarding prevention and care in HIV vaccine trials.Rika Moorhouse, Catherine Slack, Michael Quayle, Zaynab Essack & Graham Lindegger - 2014 - BMC Medical Ethics 15 (1):51.
    South Africa is a major hub of HIV prevention trials, with plans for a licensure trial to start in 2015. The appropriate standards of care and of prevention in HIV vaccine trials are complex and debated issues and ethical guidelines offer some direction. However, there has been limited empirical exploration of South African stakeholders’ perspectives on ethical guidance related to prevention and care in HIV vaccine trials.
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Vulnerability in research and health care; describing the elephant in the room?Samia A. Hurst - 2008 - Bioethics 22 (4):191–202.
    Despite broad agreement that the vulnerable have a claim to special protection, defining vulnerable persons or populations has proved more difficult than we would like. This is a theoretical as well as a practical problem, as it hinders both convincing justifications for this claim and the practical application of required protections. In this paper, I review consent-based, harm-based, and comprehensive definitions of vulnerability in healthcare and research with human subjects. Although current definitions are subject to critique, their underlying assumptions may (...)
    Download  
     
    Export citation  
     
    Bookmark   97 citations